Natural Ingredients and Products Directory is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Exhibiting At: 

NATUREX Inc.

United States

Naturex manufactures natural specialty ingredients for the food and beverage, nutrition and health and personal care industries. Naturex employs over 1,700 people and has 15 production units located in Europe, the United States, Brazil, Australia, Morocco, India and Chile. The group also has 25 sales offices worldwide. Naturex expertise and technologies maximize the full potential of botanicals. Our nutrition and health department develops botanical extracts and natural ingredient concepts backed by scientific studies for pharmaceutical, dietary supplement and nutraceutical applications.

Trademarks

  • Svetol(R)
  • Flowens(tm)
  • Pacran(tm)
  • Powergrape(R)
  • Cereboost(R)
  • Cyracos(R)
  • Lifenol(R)
  • Glucevia(R)
  • Ellirose(tm)

Associations

  • American Botanical Council (ABC)
  • American Herbal Products Association (AHPA)
  • Drug Chemical & Associated Technologies Association (DCAT)
  • Institute of Food Technologists (IFT)
  • Personal Care Products Council
  • Society of Cosmetic Chemists (SCC)

Patents

Process for sterilization and disinfecting of agriculture and botanic products
The present invention relates generally to the sterilization and disinfection of agricultural and botanical products such as botanical powders. More particularly, the present invention is directed towards the use of HBS technology whereby contaminated agricultural products are contacted, at ambient pressure, with an oxidant such as nascent oxygen or hydroxyl radicals thus resulting in the oxidization and destruction of the contaminating microorganisms.
Patent Number: 6,682,697 | Patent Date: 01/27/2004
Treatment of sexual dysfunction with an extract of Lepidium meyenii roots
An isolated composition obtained by extracting Lepidium meyenii roots is provided. The composition is substantially free of cellulose and comprises between about 5% and about 9% of benzyl isothiocyanate, between about 1% and about 3% of Lepidium sterol component, between about 20% and about 30% of Lepidium fatty acid component, and about 10% or more of macamide component. The composition is prepared by a process which comprises contacting Lepidium meyenii roots with a first aqueous solvent of about 90% vol-% or more water, then separating the residual Lepidium meyenii root material from the first contacted aqueous solvent, then contacting the residual Lepidium meyenii root material with a second aqueous solvent which comprises a mixture of an alcohol and water having about 90 vol-% alcohol or more to form a liquor, and then finally concentrating the liquor to obtain the composition. The composition can be used for treating cancer and sexual dysfunction.
Patent Number: 6,428,824 | Patent Date: 08/06/2002
Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
d are products including trihydroxystilbenes and glycosylated derivatives thereof. Also provided are compositions containing these products with an aqueous solvent, particularly and alcohol-water mixture, and reverse phase chromatographic methods for isolating and purifying the compositions from plant materials. The products have biological activity, including anti-tumor activity.
Patent Number: 6,361,815 | Patent Date: 03/26/2002
Extract of Lepidium meyenii roots for pharmaceutical applications
An isolated composition obtained by extracting Lepidium meyenii roots is provided. The composition is substantially free of cellulose and comprises between about 5% and about 9% of benzyl isothiocyanate, between about 1% and about 3% of Lepidium sterol component, between about 20% and about 30% of Lepidium fatty acid component, and about 10% or more of macamide component. The composition is prepared by a process which comprises contacting Lepidium meyenii roots with a first aqueous solvent of about 90% vol-% or more water, then separating the residual Lepidium meyenii root material from the first contacted aqueous solvent, then contacting the residual Lepidium meyenii root material with a second aqueous solvent which comprises a mixture of an alcohol and water having about 90 vol-% alcohol or more to form a liquor, and then finally concentrating the liquor to obtain the composition. The composition can be used for treating cancer and sexual dysfunction.
Patent Number: 6,267,995 | Patent Date: 07/31/2001
Imidazole alkaloids from Lepidium meyenii and methods of usage
The present invention relates to novel imidazole alkaloid compounds that have been isolated as a form of chloride salt from a root extract of Lepidium meyenii Walp, with the common name Maca, and identified below as 1,3-bis(phenylmethyl)-4,5-dimethyl-1H-imidazlium chloride and 1,3-bis(phenylmethyl)-2,4,5-trimethyl-1H-imidazlium chloride, compounds (1) and (2), respectively. ##STR1## The present invention further relates to the use of these novel compounds (1) and (2) to treat proliferative diseases, such as but not limited to cancer.
Patent Number: 6,878,731 | Patent Date: 04/12/2005
Compositions and methods for their preparation from lepidium
Patent Number: 6,552,206 | Patent Date: 04/22/2003
Naturex group and the Personal Care market

Personal Care

Naturex group and the Personal Care market

Personal Care

Naturex group, the Nutrion & Health market

Naturex group, the Nutrion & Health market

Naturex group, the Nutrion & Health market

Naturex group, the Nutrion & Health market

Naturex group, the Food & Beverage market

Naturex group, the Food & Beverage market

Naturex group, the Food & Beverage market

NAT Taste

Feedback